AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimigoal-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Metcure Remedies Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimigoal-M1 Tablet PR

DiaBeta-Duo tablets are anti-diabetic medications combining two active ingredients for adult type 2 diabetes management. They help regulate blood glucose. Always take DiaBeta-Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them using fast-acting glucose sources (e.g., sugary foods or juice). Avoid alcohol, which increases hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. DiaBeta-Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Disclose any history of heart disease to your doctor before starting this medication. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring is essential, along with potential blood tests to monitor blood cell counts and liver function as directed by your physician.

Primary Ingredients of Glimigoal-M1 Tablet PR

No text provided to rephrase.

Uses of Glimigoal-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimigoal-M1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Glimigoal-M1 Tablet PR with a meal.

Common Side effects of Glimigoal-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigoal-M1 Tablet PR:

Follow your doctor's instructions or refer to the product label for usage guidelines. Take Glimigoal-M1 Tablet PR with meals.

How Glimigoal-M1 Tablet PR works:

Glimigoal-M1 PR tablets contain a dual-action antidiabetic formula: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimigoal-M1 Tablet PR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimigoal-M1 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The medication Glimigoal-M1 Tablet PR poses a risk to breastfeeding infants. Evidence indicates potential infant toxicity from this drug.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimigoal-M1 Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimigoal-M1 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimigoal-M1 Tablet PR to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Initiate Glimigoal-M1 Tablet PR therapy at a reduced dosage for patients exhibiting mild to moderate liver dysfunction; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Glimigoal-M1 Tablet PR :

Should you forget a dose of Glimigoal-M1 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glimigoal-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimigoal-M1 Tablet PR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimigoal-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimigoal-M1 Tablet PR and seek immediate medical attention.
Glimigoal-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Glimigoal-M1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimigoal-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glimigoal-M1 Tablet PR can indeed lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimigoal-M1 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glimigoal-M1 Tablet PR
45
MRP 55
18% off